// App-Quantinova.ai

AEP405 : Aldo-keto reductase (AKR) 1C1 – a potential driver of cell cycle progression in hepatocellular carcinoma

Researchers

Presenter

  • Ismael da Conceiao

Principal Investigators

  • Nikolaos Nikolaou

  • Anastasia Arvaniti

  • Laura Gathercole

  • Leanne Hodson

  • Jeremy Tomlinson

Medical Centers

  • Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Headington, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic fatty liver disease

  • Liver cancer

  • Fatty Liver Disease

  • Metabolic syndrome

  • Solid malignancies

Biomarkers

  • p53

  • Cyclin dependent kinase 1

  • Cyclin dependent kinase 2

  • Cyclin dependent kinase 6

Drug/Treatment

  • Hydroxyprogesterone caproate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved